LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 10 | uM | LJP5 | 1 | M19 | 72 | hr | 962 | 1443 | 10714 | 0.1347 | 0.1236 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 2 | M19 | 72 | hr | 962 | 1597 | 10507 | 0.1520 | 0.1583 |
MCF 10A | Erlotinib | 10 | uM | LJP5 | 3 | M19 | 72 | hr | 962 | 1465 | 10315 | 0.1420 | 0.1307 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 1 | N12 | 72 | hr | 962 | 9014 | 10693 | 0.8429 | 0.9040 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 2 | N12 | 72 | hr | 962 | 9264 | 10740 | 0.8625 | 0.9168 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 962 | 9310 | 10641 | 0.8749 | 0.9244 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 962 | 5273 | 10693 | 0.4931 | 0.6317 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 962 | 5296 | 10740 | 0.4931 | 0.6323 |
MCF 10A | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 962 | 5095 | 10641 | 0.4788 | 0.6173 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 962 | 2185 | 10693 | 0.2043 | 0.2663 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 962 | 2434 | 10740 | 0.2266 | 0.3056 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 962 | 2183 | 10641 | 0.2051 | 0.2665 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 1 | N09 | 72 | hr | 962 | 1442 | 10693 | 0.1349 | 0.1235 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 2 | N09 | 72 | hr | 962 | 1522 | 10740 | 0.1417 | 0.1408 |
MCF 10A | Gefitinib | 1.11 | uM | LJP6 | 3 | N09 | 72 | hr | 962 | 1446 | 10641 | 0.1359 | 0.1247 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 962 | 1355 | 10693 | 0.1267 | 0.1036 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 962 | 1467 | 10740 | 0.1366 | 0.1288 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 962 | 1384 | 10641 | 0.1301 | 0.1106 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 1 | N07 | 72 | hr | 962 | 1261 | 10693 | 0.1179 | 0.0810 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 2 | N07 | 72 | hr | 962 | 1109 | 10740 | 0.1033 | 0.0417 |
MCF 10A | Gefitinib | 10 | uM | LJP6 | 3 | N07 | 72 | hr | 962 | 1418 | 10641 | 0.1333 | 0.1184 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 962 | 9835 | 10714 | 0.9180 | 0.9514 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 962 | 9886 | 10507 | 0.9408 | 0.9649 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 962 | 9624 | 10315 | 0.9330 | 0.9599 |
MCF 10A | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 962 | 9718 | 10714 | 0.9070 | 0.9447 |